Introduction {#sec1}
============

Sudden sensorineural hearing loss (SSNHL) occurs with an incidence of 5--20 cases per 100,000 persons per year.[@bib1] Classically, it is defined as new onset unilateral hearing loss that occurs within a time period of three consecutive days.[@bib2], [@bib3] In addition to sensorineural hearing loss (SNHL), patients can report aural fullness, tinnitus, and vestibular symptoms.[@bib4], [@bib5], [@bib6] One of the leading theories regarding the etiology of SSNHL includes an inflammatory insult related to a viral infection.[@bib7], [@bib8], [@bib9], [@bib10], [@bib11], [@bib12], [@bib13], [@bib14]

Numerous studies have investigated treatment options for SSNHL. Steroid therapy, via either oral corticosteroids or intratympanic injection, is the current standard of care for treatment of SSNHL.[@bib3], [@bib15], [@bib16], [@bib17], [@bib18], [@bib19] Formally speaking, however, the efficacy of steroid treatment for SSNHL has never been proven with a randomized, placebo-controlled trial.[@bib20] Further confounding the picture, it has also been reported that 32%--65% of cases recover without any treatment.[@bib3], [@bib5], [@bib16]

Prior studies have principally utilized audiometric data, including pure tone averages (PTA) and word recognition scores (WRS) to quantify audiometric outcomes following SSNHL. In brief, the PTA is considered as the hearing sensitivity averaged over four standard frequencies: 500, 1000, 2000, and 4000 Hz.[@bib21], [@bib22] WRS is a measure of intelligibility of a standard list of monosyllables, measured as a percentage of correctly recognized words.[@bib3], [@bib23] In some studies, PTA and WRS have been found to track one another; WRS typically improves with decreasing PTA thresholds.[@bib15] Few studies, however, have addressed whether the converse clinical scenario may be true: can WRS significantly improve in the absence of PTA improvement?

Herein, we examine the hypothesis that there may be a subset of patients with SSNHL who have improved WRS despite stable PTA. Identification of this novel patient population has implications both for patient counseling and for the pathophysiology of SSNHL.

Materials and methods {#sec2}
=====================

Basic inclusion and exclusion criteria {#sec2.1}
--------------------------------------

We retrospectively analyzed patients with an ICD-9 code diagnosis of SSNHL (388.2) treated at our tertiary care center between 2011 and 2014. Inclusion criteria included at least 10 dB or greater difference in sensorineural hearing loss as measured by PTA in affected versus unaffected ears and follow-up of at least 60 days later with an audiogram. Exclusion criteria included first audiogram greater than 30 days post symptoms, Meniere\'s disease, otosclerosis, immune mediated SNHL, perilymph fistula, non-SNHL, ototoxicity, bilateral severe SNHL, congenital SNHL, mixed SNHL with conductive components, fluctuating SNHL, ipsilateral vestibular schwannoma, or patients without available audiograms from our institution. This study was approved by our Institutional Review Board (IRB), protocol \#14-116H.

Out of the overall sample of patients with SSNHL, we aimed to identify patients who had stable PTA and improving WRS. To identify this cohort of patients, only patients with at least 10 dB difference between affected versus non-affected ears\' PTAs was examined. Additionally, we required patients to have follow-up in a 2--18 month period.

Audiometric data {#sec2.2}
----------------

Audiologists from our institution conducted all audiograms analyzed in this study. PTA was calculated in the standard method with averaging of thresholds at 500, 1000, 2000, and 4000 Hz.[@bib24] WRS here were calculated based on four sets of 50 word monosyllable sets (CID W-22),[@bib3], [@bib24] which at our institution is presented in a pre-recorded format. An abbreviated version of these lists was utilized at our institution with a list of 10 words out of the 50 from each of the four sets that have been found to be highly predictive of a subject\'s WRS. If all 10 words were answered correctly, then a score of "pass" is registered. However, if one out of ten answers is incorrect, then the full 50-word list is tested as a default. This method involving an abbreviated list has been internally validated by our audiologists. Patients with WRS recorded as "pass" were therefore designated a value of 100% while those recorded as below threshold or no words recognized as 0%. All words used in the lists are open-set male English speakers tested usually at a threshold of 70 dB. PTAs recorded as above threshold were assigned a value of 100 dB.

Statistical analysis and reporting of audiometric data {#sec2.3}
------------------------------------------------------

We utilized a standardized method for reporting collective audiometric data as agreed upon by the Hearing Committee of the American Academy of Otolaryngology-Head and Neck Surgery.[@bib25] Statistical analyses were carried out using Microsoft Excel (Redmond, Washington). Two tailed, paired student\'s *t*-test was utilized to generate *P*-values. We consider *P*-value less than 0.05 to be statistically significant. All ± refer to standard deviation (SD) unless otherwise specified.

Results {#sec3}
=======

Baseline sample of patients with SSNHL {#sec3.1}
--------------------------------------

We queried all electronic medical records at the study institution from 2011 to 2014 for patients with a primary or secondary ICD-9 diagnosis of 388.2, which generated a list of 569 patients. [Fig. 1](#fig1){ref-type="fig"} is a flow chart that demonstrates inclusion and exclusion of study patients. Patients without study institution audiograms were excluded (*n* = 74). Any patient with an audiogram greater than 30 days from onset of symptoms and/or treatment was excluded (*n* = 112). Additionally, patients with Meniere\'s disease (or "cochlear hydrops") (*n* = 16), immune mediated SNHL (*n* = 1), ototoxicity (*n* = 1), vestibular schwannomas (*n* = 2), perilymph fistula (*n* = 2), otosclerosis (*n* = 6), bilateral severe SNHL (*n* = 6), congenital SNHL (*n* = 2), mixed SNHL and conductive hearing loss (*n* = 8), and fluctuating SNHL (*n* = 10) were all excluded ([Fig. 1](#fig1){ref-type="fig"}).Fig. 1Diagram of patients included and excluded in this study. All audiograms considered were obtained at our institution.Fig. 1

We identified a range of PTAs and WRS, generally in agreement with prior description of patients with SSNHL.[@bib15] Results of this first audiogram are plotted in [Fig. 2](#fig2){ref-type="fig"}. The average age of these patients was 56.1 ± 14.6 years old with a range from 8 to 90 years old. There was a male preponderance at 54.69% (*n* = 175), and 45.31% females (*n* = 145). The average initial WRS in the affected ear was 53.4 ± 38.3% ranging from 0% to 100% while the average PTA was 49.1 ± 29.3 dB ranging from 0 dB to 118 dB. The affected ear was found to have a significantly different PTA and WRS from the unaffected ear (*P* \< 0.001).Fig. 2Word recognition scores and pure tone averages of affected side from patients with SSNHL on first audiogram presented in standard plot diagram as proposed by American Academy of Otolaryngology-Head and Neck Surgery Hearing Loss Scale.[@bib25] Each box represents the number of patients that have a result within its designated box. *n* = 314.Fig. 2

Subgroup analysis of patients with improved WRS and stable PTA {#sec3.2}
--------------------------------------------------------------

We observed that the majority of patients improved both their WRS and their PTAs from initial audiogram (WRS 46.1 ± 38.0% and PTA 56.6 ± 26.9 dB) to final follow up audiograms (WRS 70.25 ± 34.4% and PTA 36.0 ± 27.5 dB) ([Fig. 3](#fig3){ref-type="fig"}). This improvement in WRS and PTAs between initial audiogram to final follow up audiograms is significant (*P* \< 0.001). While these patients improved their WRS and PTAs, we do not set a specific threshold for recovery being mindful of the floor effect observed when such thresholds for improvement are set.[@bib26]Fig. 3Changes in word recognition scores and pure tone averages comparing the initial audiogram at our institution and the last available audiogram (follow-up: 2--18 months). Presented in standard format as proposed by American Academy of Otolaryngology-Head and Neck Surgery Hearing Loss Scale.[@bib25]*n* = 113.Fig. 3

Out of the original cohort of SSNHL patients, using the aforementioned inclusion and exclusion criteria we identified 13 patients with improved WRS despite stable PTA ([Fig. 4](#fig4){ref-type="fig"}). These patients had an average age of 60.6 ± 11.8 years with a range of 43--86 years old. There were 8 male and 5 female patients. The WRS of these patients increased on average by 23.8 ± 9.8% (*P* = 0.031), with a range of 12--42%. Although the starting WRS were across a range, these improvements are not likely to be due to chance.[@bib26] For these patients, however, the PTAs remained essentially stable at an average of −0.8 ± 6.6 dB (*P* = 0.92) with a range of −13 to +10 dB ([Fig. 5](#fig5){ref-type="fig"}). We defined stable or worsening PTA here from −20 dB to +10 dB. As a comparison, there is a subset of patients ([Fig. 4](#fig4){ref-type="fig"}) with stable PTAs and worsening WRS in the same range as the previous group. From this cohort, we similarly excluded patients with initial WRS greater than or equal to 90% thereby identifying five patients in this category ([Fig. 5](#fig5){ref-type="fig"}).Fig. 4Highlighted are two groups of patients for further analysis. In solid gray are patients whose WRS improved with overall stable PTAs (*n* = 13). The complementary group, hatched, is used as a comparison with worsening WRS and stable PTA (*n* = 11). Only 5 patients from this group were considered for further analysis as the remainder had starting WRS ≥90%.Fig. 4Fig. 5Selected group of patients from [Fig. 4](#fig4){ref-type="fig"} with specific patient characteristics. The starting/initial audiogram WRS and PTA are listed along with the final WRS and PTA on last available follow up. "PO, IT" = PO steroids followed by salvage intratympanic steroid injection. "PO + IT" = PO and concurrent intratympanic injection. Averages for each column are listed. The WRS for the first cohort of patients was significantly improved from initial to last audiograms as indicated by asterisk (*P* \< 0.05).Fig. 5

This subgroup of patients have an average age of 65.6 ± 17.2 years with a range of 37--78 years old that include 2 male and 3 female patients. On average, these patients had a worsening WRS of 22.0 ± 11.6% (*P* = 0.15) ranging from 10% to 40% and PTA remaining stable at 0.2 ± 7.82 dB (*P* = 0.99) ranging from −10 to +8 dB. While these two patient groups are very limited in number, the average initial WRS and PTA between these two cohorts are not statistically different (WRS *P* = 0.984, PTA *P* = 0.347).

The subgroup of patients with improved WRS despite stable PTA presented with varying degrees of classic symptoms associated with SSNHL, including ear blockage, tinnitus, dizziness, and vertigo ([Fig. 5](#fig5){ref-type="fig"}). These patients presented to our institution up to four weeks from the onset of symptoms. With respect to treatments received, six patients received oral prednisone taper and either concurrent or salvage intratympanic steroid injections, while the remaining seven patients were treated with oral steroids only. The comparison group similarly presented with tinnitus, ear blockage, and dizziness. One patient was found to have an incidental small vestibular schwannoma on the non-SSNHL side. Two of these patients were treated with oral steroids alone, one with oral steroids followed by intratympanic steroid injection, and one with oral steroid followed by intravenous methylprednisolone. One patient declined treatment. Review of medications taken by patients in either group did not reveal any class of medication that was unique to each in a significant way (data not shown). One patient from the first cohort did have a history of eustachian tube dysfunction requiring tympanostomy tubes. Additionally, we evaluated cardiovascular risk factors between the two groups, including hypertension, hyperlipidemia, diabetes mellitus, history of myocardial infarction, transient ischemic attacks, congestive heart failure, or smoking status. There was no clear difference between the two groups (data not shown).

Discussion {#sec4}
==========

We have identified a small but distinct group of patients whose WRS increases despite stable or worsening PTAs. We found no obvious distinct feature of this patient population in comparison to a complementary group of patients without improved WRS ([Fig. 4](#fig4){ref-type="fig"}, [Fig. 5](#fig5){ref-type="fig"}). Of note, we observed that six out of 13 patients who had improved WRS did receive both oral and intratympanic steroids ([Fig. 5](#fig5){ref-type="fig"}), although this number is too small to draw firm conclusions relative to the group without improved WRS. While the starting WRS for the patient population of interests were across a range, these improvements are unlikely to be due to chance.[@bib26] Specifically, when analyzing this group of 13 patients, 11 of them met criteria for significant change in word recognition score as defined by a binomial model of variance based on the starting value of the initial WRS, as first described by Thornton and Raffin.[@bib27]

The identification of this patient cohort raises the question as to how the WRS might improve despite stable PTAs. Temporal bone histopathological studies may shed some light in this regard, as they have demonstrated that the primary site of damage in SSNHL is in hair cells and supporting cells of the organ of Corti.[@bib28], [@bib29] There are at least two potential mechanisms by which patients might experience improvement in WRS without improvement in PTA. One explanation is that these patients simply experience broader recovery within the cochlea. That is, although PTA does not significantly improve because the density of functional hair cells remains decreased on average around each of the tested frequencies, there is a greater density of hair cell recovery overall across the cochlea to result in improved WRS. Another explanation is that these patients might demonstrate a superior ability to decode the new, distorted signal presented to the brain from the affected ear. Such adaptation could be analogous to the process by which patients learn to interpret new signals presented to the brain following cochlear implantation,[@bib30] and future treatments for SSNHL might therefore focus on similarly "re-training" the affected ear. Such approaches have been previously attempted for patients with hearing loss,[@bib31] although definitive studies remain to be performed.

There are several limitations of our study. First, we are unable to draw any conclusions from a statistical perspective about the two patient populations we identified. Second, this study does not define specific criteria for the diagnosis of SSNHL, instead relying on clinician\'s reporting based on a standardized coding system, ICD-9, that is tied to compensation for all providers. Third, in terms of WRS protocol, if the subject misses one of the initial 10 words, then the full 50-word list is tested. While this method has been internally validated by our audiologists, we recognize that fewer words may increase intersubject variability, and this is a limitation of this technique.[@bib26] Finally, there may be more patients with increased WRS despite stable PTA that are lost to follow-up. Indeed, many patients did not have serial audiograms. It is possible that patients partially or completely recovered.

In summary, this study identifies a novel patient population that merits further investigation. It is clear that a small subset of patients have improved word recognition despite unchanged hearing thresholds. A large-scale study would lend more power to such an investigation. Such a study might allow for finer dissection of potential confounders or associated symptoms that could impact intervention.

Conclusion {#sec5}
==========

We identify a novel cohort of SSNHL patients that have failed treatment as measured by PTA, but who have increased WRS. This patient cohort has important implications for patient counseling and understanding the etiology and natural history of SSNHL.
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